血清白蛋白预测癌症术后并发症的研究进展  

Research progress in predicting postoperative complications of cancer with serum albumin

作　　者：李燕 赵雷 LI Yan;ZHAO Lei(The Sccond Clinical Medical College,Jinan University,Shenzhen 518000,China;Department of Anesthesiology,Shenzhen People's Hospital,Shenzhen 518000,China)

机构地区：[1]暨南大学第二临床医学院,广东深圳518000 [2]深圳市人民医院麻醉科,广东深圳518000

出　　处：《长春中医药大学学报》2023年第12期1418-1422,共5页Journal of Changchun University of Chinese Medicine

基　　金：深圳市海外高层次人才创新创业专项基金项目(KQTD2016113015442590)。

摘　　要：血清白蛋白是一种传统的营养标志物,具有低成本、易获取的优点。近年来,其与炎症和肿瘤的密切关系受到越来越多学者的关注,不少研究称术前低蛋白血症与术后伤口感染、吻合口瘘、心肺疾病、住院时间延长、死亡率增加等相关性强。相对于单独使用,血清白蛋白联合其他指标预测肿瘤术后并发症的能力更有价值,有助于指导临床医师早期采取干预措施,减轻医疗支出负担。静脉输注白蛋白对改善手术患者预后是否有效目前尚有争议,还需进一步研究。Serum albumin is a traditional nutritional biomarker that has the advantages of low cost and easy availability.In recent years,its close relationship with inflammation and tumors has received increasing attention from scholars.Many studies have shown that preoperative hypoalbuminemia is closely related to complications such as postoperative wound infection,anastomotic leak,and cardiovascular and pulmonary diseases.In addition,it is also strongly associated with prolonged hospital stay and increased mortality.Compared with using it alone,the ability of serum albumin combined with other indicators to predict postoperative complications of cancer surgery is more valuable,which can help guide clinicians to take early intervention measures and reduce the burden of medical expenses.The efficacy of intravenous albumin infusion in improving the prognosis of surgical patients is still controversial and further research is needed.

关 键 词：血清白蛋白 术后并发症 预测作用 

分 类 号：R730.6[医药卫生—肿瘤]